Skip to main content
SpringerLink
Log in

Surgical Management of Recurrent Medullary Thyroid Cancer

  • Chapter
  • First Online:
Medullary Thyroid Cancer

  • 633 Accesses

Abstract

Medullary thyroid cancer (MTC) is a relatively rare neuroendocrine cancer of the thyroid, accounting for up to 5 % of all thyroid cancers in the USA. Unlike differentiated thyroid cancers, which arise from the follicular cells, MTC arises from the parafollicular, or C-cells, of the thyroid. As a result, MTC is not sensitive to radioactive iodine, and therefore, the initial surgical resection is critical for obtaining biochemical and anatomic control.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25(6):567–610.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Modigliani E, Cohen R, Campos JM, Conte-Devolx B, Maes B, Boneu A, et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d’etude des tumeurs a calcitonine. Clin Endocrinol (Oxf) 1998;48(3):265–73.

    Google Scholar 

  3. Balentine CJ, Chen H. Chasing calcitonin: reoperations for medullary thyroid carcinoma. Ann Surg Oncol. 2015;22(1):7–8.

    Article  PubMed  Google Scholar 

  4. Rendl G, Manzl M, Hitzl W, Sungler P, Pirich C. Long-term prognosis of medullary thyroid carcinoma. Clin Endocrinol (Oxf). 2008;69(3):497–505.

    Article  CAS  Google Scholar 

  5. Ukkat J, Gimm O, Brauckhoff M, Bilkenroth U, Dralle H. Single center experience in primary surgery for medullary thyroid carcinoma. World J Surg. 2004;28(12):1271–4.

    Article  PubMed  Google Scholar 

  6. Weber T, Schilling T, Frank-Raue K, Colombo-Benkmann M, Hinz U, Ziegler R, et al. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. Surgery. 2001;130(6):1044–9.

    Article  CAS  PubMed  Google Scholar 

  7. Rowland KJ, Jin LX, Moley JF. Biochemical cure after reoperations for medullary thyroid carcinoma: a meta-analysis. Ann Surg Oncol. 2015;22(1):96–102.

    Article  PubMed  Google Scholar 

  8. Verbeek HH, Meijer JA, Zandee WT, Kramp KH, Sluiter WJ, Smit JW, et al. Fewer cancer reoperations for medullary thyroid cancer after initial surgery according to ATA guidelines. Ann Surg Oncol. 2015;22(4):1207–13.

    Article  PubMed  Google Scholar 

  9. Machens A, Schneyer U, Holzhausen HJ, Dralle H. Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J Clin Endocrinol Metab. 2005;90(4):2029–34.

    Article  CAS  PubMed  Google Scholar 

  10. Machens A, Gimm O, Ukkat J, Hinze R, Schneyer U, Dralle H. Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis. Cancer. 2000;88(8):1909–15.

    Article  CAS  PubMed  Google Scholar 

  11. Ismailov SI, Piulatova NR. Postoperative calcitonin study in medullary thyroid carcinoma. Endocr Relat Cancer. 2004;11(2):357–63.

    Article  CAS  PubMed  Google Scholar 

  12. Elisei R, Pinchera A. Advances in the follow-up of differentiated or medullary thyroid cancer. Nat Rev Endocrinol. 2012;8(8):466–75.

    Article  CAS  PubMed  Google Scholar 

  13. Pellegriti G, Leboulleux S, Baudin E, Bellon N, Scollo C, Travagli JP, et al. Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging. Br J Cancer. 2003;88(10):1537–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Barbot N, Calmettes C, Schuffenecker I, Saint-Andre JP, Franc B, Rohmer V, et al. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. J Clin Endocrinol Metab. 1994;78(1):114–20.

    CAS  PubMed  Google Scholar 

  15. Yen TW, Shapiro SE, Gagel RF, Sherman SI, Lee JE, Evans DB. Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients. Surgery 2003;134(6):890–9, discussion 9–901.

    Google Scholar 

  16. Laure Giraudet A, Al Ghulzan A, Auperin A, Leboulleux S, Chehboun A, Troalen F, et al. Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times. Eur J Endocrinol. 2008;158(2):239–46.

    Google Scholar 

  17. Kebebew E, Kikuchi S, Duh QY, Clark OH. Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer. Arch Surg. 2000;135(8):895–901.

    Article  CAS  PubMed  Google Scholar 

  18. Dotzenrath C, Goretzki PE, Cupisti K, Simon D, Witte J, Yang Q, et al. Is there any consensus in diagnostic and operative strategy with respect to medullary thyroid cancer? A questionnaire answered by 73 endocrine surgical units. Langenbeck’s archives of surgery/Deutsche Gesellschaft fur Chirurgie. 2001;386(1):47–52.

    Article  CAS  PubMed  Google Scholar 

  19. Frank-Raue K, Buhr H, Dralle H, Klar E, Senninger N, Weber T, et al. Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype. Eur J Endocrinol. 2006;155(2):229–36.

    Article  CAS  PubMed  Google Scholar 

  20. Fernandez Vila JM, Peix JL, Mandry AC, Mezzadri NA, Lifante JC. Biochemical results of reoperations for medullary thyroid carcinoma. Laryngoscope 2007;117(5):886–9.

    Google Scholar 

  21. Gimm O, Dralle H. Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage-oriented approach justified? Surgery 1997;122(6):1124–30 (Discussion 30-1).

    Google Scholar 

  22. Gimm O, Ukkat J, Dralle H. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. World J Surg. 1998;22(6):562–7 (Discussion 7-8).

    Google Scholar 

  23. Moley JF, Dilley WG, DeBenedetti MK. Improved results of cervical reoperation for medullary thyroid carcinoma. Ann Surg. 1997;225(6):734–40 (Discussion 40-3).

    Google Scholar 

  24. Buhr HJ, Kallinowski F, Raue F, Frank-Raue K, Herfarth C. Microsurgical neck dissection for occultly metastasizing medullary thyroid carcinoma. Three-year results. Cancer. 1993;72(12):3685–93.

    Article  CAS  PubMed  Google Scholar 

  25. Tisell LE, Hansson G, Jansson S, Salander H. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery. 1986;99(1):60–6.

    CAS  PubMed  Google Scholar 

  26. Fialkowski E, DeBenedetti M, Moley J. Long-term outcome of reoperations for medullary thyroid carcinoma. World J Surg. 2008;32(5):754–65.

    Article  PubMed  Google Scholar 

  27. Chen H, Roberts JR, Ball DW, Eisele DW, Baylin SB, Udelsman R, et al. Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection. Ann Surg. 1998;227(6):887–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Cayonu M, Acar A, Eryilmaz A, Oguz O. Surgical approach and outcomes for revision surgery of the central neck compartment. J Craniofac Surg. 2014;25(5):1797–800.

    Article  PubMed  Google Scholar 

  29. Hartl DM, Travagli JP. Central compartment neck dissection for thyroid cancer: a surgical technique. World J Surg. 2011;35(7):1553–9.

    Article  PubMed  Google Scholar 

  30. Palme CE, Freeman JL. Surgical strategy for thyroid bed recurrence in patients with well-differentiated thyroid carcinoma. J Otolaryngol. 2005;34(1):7–12.

    Article  PubMed  Google Scholar 

  31. Steward DL. Update in utility of secondary node dissection for papillary thyroid cancer. J Clin Endocrinol Metab. 2012;97(10):3393–8.

    Article  PubMed  Google Scholar 

  32. Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 2006;140(6):1000–5 (Discussion 5-7).

    Google Scholar 

  33. Pai SI, Tufano RP. Central compartment neck dissection for thyroid cancer. Technical considerations. ORL J Otorhinolaryngol Relat Spec. 2008;70(5):292–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Endocrine Surgery, Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA

    Jason A. Glenn & Tracy S. Wang

Authors
  1. Jason A. Glenn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tracy S. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tracy S. Wang .

Editor information

Editors and Affiliations

  1. Associate Professor of Surgery; Chief, Section of Endocrine Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    Tracy S. Wang

  2. Donald C. Ausman Family Foundation Professor in Surgery and Chair, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    Douglas B. Evans

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Glenn, J.A., Wang, T.S. (2016). Surgical Management of Recurrent Medullary Thyroid Cancer. In: Wang, T., Evans, D. (eds) Medullary Thyroid Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-39412-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-39412-1_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-39410-7

  • Online ISBN: 978-3-319-39412-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation